性能参数

产品名称

Macitentan

规格

10mM (in 1mL DMSO) 5mg 25mg 100mg

货号

GOY-Y2864

 含量

>98.00%

CAS

441798-33-0

别名

N/A

化学名

5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-N-(propylsulfamoyl)pyrimidin-4-amine

分子式

C19H20Br2N6O4S

分子量

分子量 588.27

溶解度

≥ 24.4mg/mL in DMSO

储存条件

Store at -20°C

General tips

用途

仅供科研

价格

电询

详细内容

Macitentan is a new dual ETA/ETB endothelin (ET) receptor antagonist, with mean IC50 values of 0.5 ± 0.2 nM (n= 17) to inhibit the binding of 125I-ET-1 to recombinant ETA receptors, and of 391±182 nM (n= 17) for ETB receptors in Chinese hamster ovary cells [1].

ETA and ETB are ET receptors, both of them mediate the detrimental actions of ET-1, and dual blockade of them may be necessary [1].

In microsomal membranes of human-ETA and ETB-overexpressing Chinese hamster ovary cells, macitentan inhibited the binding between 125I-ET-1 and recombinant ETA receptors, with a mean IC50 value of 0.5 ± 0.2 nM (n= 17). The mean IC50 value for ETB receptors was 391±182 nM (n= 17). Macitentan completely inhibited the effect that ET-1 increased intracellular calcium in non-recombinant cells [1].

Intravenous administrated macitentan had a volume of distribution largely exceeding plasma volume and a terminal half-life of 2 h in rats. Macitentan was hence metabolized to its major and the only circulating metabolite, a dual ET receptor antagonist, ACT-132577. ACT-132577 also had a volume of distribution greater than the plasma volume. It showed a longer half-life than macitentan in rats. In rat, multiple oral dosing of macitentan at a dose of 10 mg/kg led to 4 to 5-fold higher exposure levels of ACT-132577 than those of the parent compound [1].

1-十二烯 分析标准品， ≥99.5% (GC)  2,4,5-涕丙酸  分析标准品

1-十二烯 95%  氯化镧,无水 99.9% (REO),10目

1-癸烯 95%  氧化铽 99.99% metals basis

1-癸烯 分析标准品，≥99.5% (GC)  盐酸硫胺 AR,99.0%

3,3-二甲基-1-丁烯 95%  盐酸硫胺 分析标准品

乙硫醇 98%  盐酸硫胺 USP

Evans Blue tetrasodium salt1g>98.00%Cas No. 314-13-6C34H24N6Na4O14S4

Etiocholanolone5 mg>98.00%Cas No. 53-42-9C19H30O2

FFN 200 dihydrochloride10mg>98.00%Cas No. N/AC11H14Cl2N4-1C35H21Cl2F2N2O13?5K

FG 7142100mg>98.00%Cas No. 78538-74-6C13H11N3O

Fumitremorgin C250μg>98.00%Cas No. 118974-02-0C22H25N3O3

Ginsenoside Ro20mg>98.00%Cas No. 34367-04-9C48H76O19